Internal Medicine, Hematology & Oncology · Orange City, FL
NPI
1336198407
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2776 Enterprise Rd, # 100
Orange City, FL, 32763
Phone (386) 774-1223
Groups this clinician bills Medicare through
Medicare paid, 2024
$946K
73,557 services
Medicare patients, 2024
510
Average age 77
Drug cost, 2024
$3.8M
1,271 prescriptions
Company payments, 2025
$26.36
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rene Cabeza was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 10,209 times for 16 patients. In total Rene Cabeza billed 73,557 services in 134 codes, and Medicare paid $946K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 10,209 | 16 | $0.27 | $2,745 |
| J1756 Injection, iron sucrose, 1 mg | Office | 8,808 | 14 | $0.16 | $1,428 |
| J0897 Injection, denosumab, 1 mg | Office | 3,541 | 28 | $20.18 | $71K |
| 85025 Blood Count | Office | 942 | 313 | $7.61 | $7,169 |
| 36415 Venipuncture Blood Collection | Office | 872 | 295 | $8.50 | $7,410 |
| 80053 Clinical Chemistry | Office | 689 | 289 | $10.35 | $7,131 |
| 84100 Clinical Chemistry | Office | 681 | 288 | $4.65 | $3,167 |
| 96372 Injection Administration | Office | 644 | 105 | $9.99 | $6,434 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 514 | 16 | $0.09 | $46.32 |
| 82607 Clinical Chemistry | Office | 479 | 257 | $14.73 | $7,054 |
| 82746 Clinical Chemistry | Office | 478 | 257 | $14.41 | $6,888 |
| 82728 Clinical Chemistry | Office | 474 | 253 | $13.36 | $6,333 |
| 83550 Clinical Chemistry | Office | 474 | 253 | $8.57 | $4,062 |
| 83540 Clinical Chemistry | Office | 473 | 253 | $6.34 | $2,999 |
| 99213 Office E&M - Established | Office | 445 | 256 | $60.40 | $27K |
By year: 2022 $992K for 111,050 services; 2023 $1.8M for 185,229 services; 2024 $946K for 73,557 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 942 | 313 | $7.61 | $7,169 |
| 36415 Venipuncture Blood Collection | 872 | 295 | $8.50 | $7,410 |
| 80053 Clinical Chemistry | 689 | 289 | $10.35 | $7,131 |
| 84100 Clinical Chemistry | 681 | 288 | $4.65 | $3,167 |
| 82607 Clinical Chemistry | 479 | 257 | $14.73 | $7,054 |
| 82746 Clinical Chemistry | 478 | 257 | $14.41 | $6,888 |
| 83550 Clinical Chemistry | 474 | 253 | $8.57 | $4,062 |
| 82728 Clinical Chemistry | 474 | 253 | $13.36 | $6,333 |
| 83540 Clinical Chemistry | 473 | 253 | $6.34 | $2,999 |
| 82378 Clinical Chemistry | 47 | 30 | $18.58 | $873 |
Medicare prescription drug claims, 2024
In 2024, the drug Rene Cabeza prescribed most often to Medicare patients was Eliquis (Apixaban), with 182 prescriptions and refills. In total Rene Cabeza wrote 1,271 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 182 | 221 | 31 | $116K |
| Anastrozole Generic | 66 | 182 | 24 | $1,930 |
| Lenalidomide Generic | 60 | 60 | Under 11 | $874K |
| Procrit Epoetin Alfa | 57 | 57 | 16 | $56K |
| Warfarin Sodium Generic | 48 | 113 | 17 | $513 |
| Xarelto Rivaroxaban | 45 | 79 | 12 | $39K |
| Dexamethasone Generic | 36 | 36 | Under 11 | $655 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 30 | 30 | Under 11 | $286K |
| Venclexta Venetoclax | 30 | 30 | Under 11 | $446K |
| Prolia Denosumab | 30 | 180 | 19 | $50K |
| Valacyclovir Valacyclovir Hcl | 30 | 61 | Under 11 | $764 |
| Hydroxyurea Generic | 30 | 82 | Under 11 | $679 |
| Benlysta Belimumab | 26 | 26 | Under 11 | $51K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 25 | 25 | Under 11 | $435 |
| Ondansetron Hcl Generic | 24 | 24 | 17 | $462 |
Brand drugs: 572 claims; generic drugs: 699 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rene Cabeza $26.36 ($26.36 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $26.36.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $26.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.